(November 7, 2023, 1:21 PM EST) -- AMARILLO, Texas — Missouri, Kansas and Idaho moved to intervene in a lawsuit challenging the U.S. Food and Drug Administration’s approval of mifepristone and misoprostol, arguing that the current plaintiffs cannot adequately represent the states’ interest and that “there is a serious risk of judicial inefficiency if not all interests are presented at once.”...